Virtual Skin Model Reveals Secrets of Skin Aging

Engineers and biologists at the University of Sheffield have shown how a recent theory - that skin has 'sleeping' stem cells which can be woken up when required - best explains how our skin constantly regrows. The research - conducted in collaboration with The Procter & Gamble Company (P&G), makers of Olay, and published in Nature Scientific Reports - has implications for combating the effects of aging and perhaps even skin cancer.

The Sheffield/P&G team developed an "in silico" (computer) model of human skin biology, capturing how the outer layers of the skin are developed and maintained over time. This model simulation or "virtual" skin was then used to test the three most popular theories of how skin cells function to regenerate our skin, the largest human organ, over a three-year period. When the simulation was run according to two of the theories, the virtual skin failed to fully regenerate. Only one theory enabled the virtual skin to still be in good shape after three years, as Dr. Xinshan Li (University of Sheffield Faculty of Engineering) and Dr. Arun Upadhyay (P&G), the lead co-authors explained in their research.

"The theory which seems to fit best says that skin has a population of 'sleeping' stem cells, which sit in the lowest layer of the skin but don't constantly divide to make new cells," Dr. Li said. "However, these sleeping cells can be called into action if the skin is damaged, or if the numbers of other types of more mature skin cells decrease, ensuring that the skin can be constantly regenerated under all conditions."

The model showed that we gradually lose these sleeping stem cells over time - which would explain why our ability to regenerate our skin reduces as we age. "Each time we wake up these cells, to heal a wound or replenish stocks of other cells, a few of them don't go back into sleep mode, so the population slowly reduces," says Dr. Li. "This explains why older skin is slower to heal and in part why our skin changes as we age. By understanding this mechanism better, it might be possible to find ways to combat the effects of aging on our skin."

Computer modelling of skin biology is the latest step in the evolution of skin science. It allows scientists to project the activity of tissues like skin that are difficult to follow in live systems for extended periods. Currently, 3-dimensional cultures of engineered human skin are viable for only a few weeks and clinical studies in humans are only practical for a few months. With the development of in silico models scientists can predict for the first time what happens in skin as it ages year by year even as it ages decade by decade.

"These models permit exploration of hypotheses in very short periods of time, relative to the lab based bench work," says Dr. Upadhyay. "In silico modelling can significantly shorten R&D programs, and help focus subsequent lab or clinical work on the options with the greatest likelihood of succeeding. This is another reason why in silico models are an effective complement to more established research tools and methods."

The ability to follow virtual skin models over decades may be especially important to skin cancer research. Environmental damage caused by UV exposure or chronic wounding can cause sleeping cells to harbor the mutations which cause skin cancers such as basal cell carcinoma, a very aggressive type of skin cancer.

"The stem cells can harbor mutations throughout the years, but with no effect if they're still in sleep mode," explains Dr. Li. "However, when they start to divide to heal a wound for example, this could trigger the cancer. If it's possible to study this phenomenon for long periods of time it may be possible to find ways to prevent the activation of mutated cells and therefore reduce the risk of developing the disease."

Other parts of the body, such as the lung or gut lining and the cornea, also regenerate in the same way as our skin. Research is already underway at the University of Sheffield to look at the healing process of the lung lining following asthma attacks.

This study is an excellent example of how computer modelling can enhance our long-term understanding of complex processes such as skin aging. Dr. Upadhyay, a physicist-turned-computational biologist, drew inspiration from the great physicist Richard Feynman in summarizing the study, noting that, "You really don't understand something until you have built it from scratch. By building the virtual skin model from a few cells into a tissue capable of self-renewal, we have moved a big step in our understanding of stem cells and skin renewal."

Skin Stem Cell Hypotheses and Long Term Clone Survival – Explored Using Agent-based Modelling X. Li, A. K. Upadhyay, A. J. Bullock, T. Dicolandrea, J. Xu, R. L. Binder, M. K. Robinson, D. R. Finlay, K. J. Mills, C. C. Bascom, C. K. Kelling, R. J. Isfort, J. W. Haycock, S. MacNeil & R. H. Smallwood Scientific Reports 3, Article number: 1904 doi:10.1038/srep01904

Most Popular Now

Philips and Medtronic Advocacy Partnersh…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a leading innovator in neurovascular therapies, today announced a strategic advocacy partnership. Delivering timely stroke...

Wearable Cameras Allow AI to Detect Medi…

A team of researchers says it has developed the first wearable camera system that, with the help of artificial intelligence (AI), detects potential errors in medication delivery. In a test whose...

New AI Tool Predicts Protein-Protein Int…

Scientists from Cleveland Clinic and Cornell University have designed a publicly-available software and web database to break down barriers to identifying key protein-protein interactions to treat with medication. The computational tool...

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...

New Research Shows Promise and Limitatio…

Published in JAMA Network Open, a collaborative team of researchers from the University of Minnesota Medical School, Stanford University, Beth Israel Deaconess Medical Center and the University of Virginia studied...

G-Cloud 14 Makes it Easier for NHS to Bu…

NHS organisations will be able to save valuable time and resource in the procurement of technologies that can make a significant difference to patient experience, in the latest iteration of...

Start-Ups will Once Again Have a Starrin…

11 - 14 November 2024, Düsseldorf, Germany. The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62...

Hampshire Emergency Departments Digitise…

Emergency departments in three hospitals across Hampshire Hospitals NHS Foundation Trust have deployed Alcidion's Miya Emergency, digitising paper processes, saving clinical teams time, automating tasks, and providing trust-wide visibility of...

MEDICA HEALTH IT FORUM: Success in Maste…

11 - 14 November 2024, Düsseldorf, Germany. How can innovations help to master the great challenges and demands with which healthcare is confronted across international borders? This central question will be...

A "Chemical ChatGPT" for New M…

Researchers from the University of Bonn have trained an AI process to predict potential active ingredients with special properties. Therefore, they derived a chemical language model - a kind of...

Siemens Healthineers co-leads EU Project…

Siemens Healthineers is joining forces with more than 20 industry and public partners, including seven leading stroke hospitals, to improve stroke management for patients all over Europe. With a total...

MEDICA and COMPAMED 2024: Shining a Ligh…

11 - 14 November 2024, Düsseldorf, Germany. Christian Grosser, Director Health & Medical Technologies, is looking forward to events getting under way: "From next Monday to Thursday, we will once again...